Elumbaring, Carmelita V.
HRN: 28-21-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/09/2025
12/16/2025
IV
2.25
Q12H
Tc CAP HR. Internal Progression Of Right Side Infiltrates
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes